AIM ImmunoTech Inc.
AIM
$0.26
$0.00-1.83%
AMEX
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.76% | -19.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.76% | -19.23% | |||
| Cost of Revenue | -90.00% | -41.18% | |||
| Gross Profit | 194.74% | 54.76% | |||
| SG&A Expenses | -3.67% | 7.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -24.39% | 20.22% | |||
| Operating Income | 24.59% | -20.64% | |||
| Income Before Tax | 27.59% | -27.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 27.59% | -27.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 27.59% | -27.13% | |||
| EBIT | 24.59% | -20.64% | |||
| EBITDA | 24.96% | -21.56% | |||
| EPS Basic | 52.00% | 7.64% | |||
| Normalized Basic EPS | 52.01% | 52.04% | |||
| EPS Diluted | 52.00% | 7.64% | |||
| Normalized Diluted EPS | 52.01% | 52.04% | |||
| Average Basic Shares Outstanding | 50.85% | 37.66% | |||
| Average Diluted Shares Outstanding | 50.85% | 37.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||